6325 Humphreys BlvdMemphis, TN 38120
Fax+1 901-259-2022
Overview of Dr. Michael
L. Madison Michael II, MD, is a neurosurgeon based in Memphis, specializing in neurosurgical oncology, skull base surgery, and open cerebrovascular disease. He graduated from the University of Tennessee Health Science Center College of Medicine in 1998. Dr. Michael has contributed extensively to the neurosurgical literature, with a strong record of peer-reviewed publications and impactful research in complex cranial surgery. His work has been widely cited, reflecting both its scientific rigor and clinical relevance. He has presented nationally and internationally at major neurosurgical and skull base meetings, sharing expertise on advanced surgical techniques, multidisciplinary care, and innovations in cranial base pathology. In addition to his clinical and academic work, Dr. Michael is recognized for his leadership in neurosurgical education and program development, helping shape the next generation of neurosurgeons through mentorship, training, and academic leadership.
Education & Training
University of Tennessee Health Science Center College of MedicineClass of 1998
Certifications & Licensure
AR State Medical License 2020 - 2028
TN State Medical License 1999 - 2028
AL State Medical License 2018 - 2026
MS State Medical License 2007 - 2026
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Centricity Practice Solution, GE Healthcare, 2012, 2014, 2017
- CMS Meaningful Use Stage 1 Certification Centricity Advance, GE Healthcare, 2012, 2014, 2017
Publications & Presentations
PubMed
- Skull Base Registries: A Roadmap.Kara P Parikh, Mustafa Motiwala, Furlan A Beer, L Madison Michael, Sanjeet V Rangarajan
Journal of Neurological Surgery. Part B, Skull Base. 2022-12-01 - Erratum: Skull Base Registries: A Roadmap.Kara P Parikh, Mustafa Motiwala, Andre Beer-Furlan, L Madison Michael, Sanjeet V Rangarajan
Journal of Neurological Surgery. Part B, Skull Base. 2022-12-01 - 13 citationsIdentifying the optimal cutoff point for MGMT promoter methylation status in glioblastoma.Ngan Nguyen, Jordan Redfield, Matthew T. Ballo, Madison Michael, Jeffrey Sorenson
CNS Oncology. 2021-09-01
Press Mentions
New Chair of Neurosurgery Honors Longstanding Clinical Partnership, Sets Sights on Future InnovationFebruary 2nd, 2026- FDA Greenlights RevBio’s Innovative Bone Glue Trial for Cranial SurgeryDecember 23rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
